Isopropylamine

Isopropylamine

SCHEMBL2802524

CC(C)N.N=[N+]([O-])[O-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylamine SCHEMBL10344016 0.72
Isopropylamine SCHEMBL10538159 0.72 MEN1 (0.43)
Isopropylamine SCHEMBL10538150 0.72 MEN1 (0.43)
Isopropylamine SCHEMBL10538168 0.72 MEN1 (0.43)
SCHEMBL305514 0.71
Isopropylamine SCHEMBL30440281 0.71
Isopropylamine SCHEMBL2909 0.71
Isopropylamine SCHEMBL19813885 0.71
SCHEMBL28550757 0.70
Isopropylamine SCHEMBL8341815 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160166604-A1 Thiol-Sensitive Positive Inotropes NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2016-06-16 US claimed
US-8980871-B2 Methods of treatment for hemolysis WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2015-03-17 US claimed
US-20100239692-A1 METHODS OF TREATMENT FOR HEMOLYSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2010-09-23 US claimed
US-20090298795-A1 Thiol-Sensitive Positive Inotropes THE JOHNS HOPINS UNIVERSITY (US) 2009-12-03 US claimed
EP-1909779-A1 THIOL-SENSITIVE POSITIVE INOTROPES Johns Hopkins University (US) 2008-04-16 EP claimed
WO-2007002444-A1 THIOL-SENSITIVE POSITIVE INOTROPES JOHNS HOPKINS UNIVERSITY (US) 2007-01-04 WO claimed
EP-4034119-A1 NOVEL METHODS Intra-Cellular Therapies, Inc. (US) 2022-08-03 EP disclosed
WO-2021062307-A1 NOVEL METHODS INTRA-CELLULAR THERAPIES, INC. (US) 2021-04-01 WO disclosed
US-20160166604-A1 Thiol-Sensitive Positive Inotropes NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2016-06-16 US disclosed
US-8980871-B2 Methods of treatment for hemolysis WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2015-03-17 US disclosed
US-20100239692-A1 METHODS OF TREATMENT FOR HEMOLYSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2010-09-23 US disclosed
US-20090298795-A1 Thiol-Sensitive Positive Inotropes THE JOHNS HOPINS UNIVERSITY (US) 2009-12-03 US disclosed
WO-2009038796-A1 METHODS OF TREATMENT FOR HEMOLYSIS WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2009-03-26 WO disclosed
EP-1909779-A1 THIOL-SENSITIVE POSITIVE INOTROPES Johns Hopkins University (US) 2008-04-16 EP disclosed
WO-2007002444-A1 THIOL-SENSITIVE POSITIVE INOTROPES JOHNS HOPKINS UNIVERSITY (US) 2007-01-04 WO disclosed